diclofenac [Ligand Id: 2714] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL139 (Arthrotec, Cambia, Cataflam, Diclofenac, Diclofenac acid, Diclofenac free acid, Diclofenaco, Las41007, LAS-41007, LAS41007, Solaraze, Voltaren, Voltaren Ophthalmic, Voltaren Xr, Voltaren-XR, Zorvolex, Zorvolex capsules) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| Aldo-keto reductase family 1 member B10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5983] [UniProtKB: O60218] | ||||||||
| ChEMBL | Inhibition of wild-type N-terminal 6-His tagged AKR1B10 (unknown origin) expressed in Escherichia coli BL21(DE3) assessed as pyridine-3-aldehyde reduction by spectrophotometry | B | 5.72 | pIC50 | 1900 | nM | IC50 | J Med Chem (2015) 58: 2047-2067 [PMID:25375908] |
| aldo-keto reductase family 1 member B/Aldose reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1900] [GtoPdb: 2768] [UniProtKB: P15121] | ||||||||
| ChEMBL | Inhibition of human AR by fluorescence assay | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2015) 58: 2047-2067 [PMID:25375908] |
| calcium/calmodulin-dependent protein kinase II alpha subunit/CaM kinase II alpha in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2359] [GtoPdb: 1555] [UniProtKB: P11275] | ||||||||
| ChEMBL | Displacement of [3H]NCS-382 from CaMK2alpha in rat brain cerebral cortex membrane homogenates assessed as inhibition constant measured after 60 mins by TopCount scintillation counting method | B | 5.29 | pKi | 5100 | nM | Ki | J Med Chem (2022) 65: 6656-6676 [PMID:35500061] |
| carbonic anhydrase 1/Carbonic anhydrase I in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL261] [GtoPdb: 2597] [UniProtKB: P00915] | ||||||||
| ChEMBL | Inhibitory activity against human carbonic anhydrase I was determined | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2004) 47: 550-557 [PMID:14736236] |
| carbonic anhydrase 2/Carbonic anhydrase II in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL205] [GtoPdb: 3092] [UniProtKB: P00918] | ||||||||
| ChEMBL | Inhibitory activity against human carbonic anhydrase II was determined | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2004) 47: 550-557 [PMID:14736236] |
| Carbonic anhydrase IV in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL281] [UniProtKB: Q95323] | ||||||||
| ChEMBL | Inhibitory activity against bovine carbonic anhydrase IV was determined | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2004) 47: 550-557 [PMID:14736236] |
| carbonic anhydrase 9/Carbonic anhydrase IX in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3594] [GtoPdb: 3055] [UniProtKB: Q16790] | ||||||||
| ChEMBL | Inhibitory activity against human carbonic anhydrase IX was determined | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2004) 47: 550-557 [PMID:14736236] |
| COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
| ChEMBL | Inhibition of COX1 in human platelet microsomes assessed as reduction in formation of oxidized TMPD using arachidonic acid as substrate preincubated for 3 to 5 mins followed by arachidonic acid addition measured for 25 secs by spectrophotometric assay | B | 4.74 | pIC50 | 18230 | nM | IC50 | ACS Med Chem Lett (2018) 9: 1045-1050 [PMID:30344915] |
| ChEMBL | Inhibition of COX-1 (unknown origin) at 10 uM | B | 5.17 | pIC50 | 6740 | nM | IC50 | Eur J Med Chem (2020) 200: 112438-112438 [PMID:32485533] |
| ChEMBL | In vitro inhibitory activity against human whole blood Prostaglandin G/H synthase 1 | B | 6.82 | pIC50 | 150 | nM | IC50 | Bioorg Med Chem Lett (1999) 9: 1773-1778 [PMID:10406640] |
| ChEMBL | Inhibition of COX1 | B | 7.15 | pIC50 | 70 | nM | IC50 | J Med Chem (2007) 50: 1425-1441 [PMID:17341061] |
| ChEMBL | Inhibition of human COX1 expressed in sf9 cells | B | 7.52 | pIC50 | 30 | nM | IC50 | J Nat Prod (2005) 68: 1514-1518 [PMID:16252917] |
| ChEMBL | Inhibition of human cyclooxygenase 1 | B | 7.82 | pIC50 | 15 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
| ChEMBL | DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) | B | 7.89 | pIC50 | 13 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| GtoPdb | - | - | 7.92 | pIC50 | 12 | nM | IC50 | J Nat Prod (2005) 68: 1514-8 [PMID:16252917] |
| ChEMBL | Inhibition of COX1 assessed as inhibition of arachidonic acid conversion to prostaglandin-E2 release | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2009) 52: 1115-1125 [PMID:19191553] |
| ChEMBL | Inhibition of cyclooxygenase 1 | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2008) 51: 6348-6358 [PMID:18811132] |
| ChEMBL | Inhibition of human COX1-mediated conversion of arachidonic acid to prostaglandin-E2 | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2008) 51: 260-270 [PMID:18095641] |
| ChEMBL | Inhibition of COX1 | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (2012) 55: 2932-2942 [PMID:22236250] |
| Cyclooxygenase-1 in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2860] [UniProtKB: O62664] | ||||||||
| ChEMBL | Inhibition of COX1 in bovine platelets assessed as formation of 12-hydroxyheptadecatrienoic acid by HPLC | B | 8.52 | pIC50 | 3 | nM | IC50 | Bioorg Med Chem (2009) 17: 558-568 [PMID:19097798] |
| Cyclooxygenase-1 in Sheep (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2949] [UniProtKB: P05979] | ||||||||
| ChEMBL | Inhibition of ovine COX1 using arachidonic acid as substrate pretreated for 5 mins followed by substrate addition and measured after 2 mins by fluorescence based enzyme immunoassay | B | 4.73 | pIC50 | 18790 | nM | IC50 | Eur J Med Chem (2019) 180: 86-98 [PMID:31301566] |
| ChEMBL | Inhibition of ovine COX1 peroxidase activity assessed as reduction of PGG2 to PGH2 by measuring oxidized TMPD level by colorimetric assay | B | 5.2 | pIC50 | 6250 | nM | IC50 | Bioorg Med Chem (2014) 22: 2855-2866 [PMID:24751552] |
| ChEMBL | Inhibition of ovine COX1 using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 2 mins by enzyme immunoassay | B | 5.2 | pIC50 | 6240 | nM | IC50 | Eur J Med Chem (2017) 127: 10-21 [PMID:28038322] |
| ChEMBL | Inhibition of ovine COX-1 using arachidonic acid as substrate preincubated with compound for 5 mins followed by substrate addition and measured after 2 mins by fluorescence spectrum analysis | B | 5.28 | pIC50 | 5230 | nM | IC50 | J Nat Prod (2023) 86: 958-965 [PMID:36880830] |
| ChEMBL | Inhibition of ovine COX -1 by colorimetric inhibitor screening assay kit method | B | 5.41 | pIC50 | 3900 | nM | IC50 | Eur J Med Chem (2019) 167: 161-186 [PMID:30771604] |
| ChEMBL | Inhibition of sheep COX-1 | B | 5.41 | pIC50 | 3880 | nM | IC50 | Eur J Med Chem (2023) 256: 115443-115443 [PMID:37182334] |
| ChEMBL | Inhibition of ovine COX-1 by EIA method | B | 6.08 | pIC50 | 840 | nM | IC50 | Eur J Med Chem (2020) 200: 112438-112438 [PMID:32485533] |
| ChEMBL | Inhibition of ovine COX-1 assessed as PGF2alpha formation using arachidonic acid as substrate pretreated with compound for 20 mins prior to substrate addition by spectrophotometric analysis | B | 6.21 | pIC50 | 610 | nM | IC50 | Eur J Med Chem (2015) 97: 104-123 [PMID:25956953] |
| ChEMBL | Inhibition of sheep COX1 using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition and measured after 5 mins by UV-visible spectrophotometric method | B | 6.32 | pIC50 | 480 | nM | IC50 | Eur J Med Chem (2020) 186: 111863-111863 [PMID:31740050] |
| ChEMBL | Inhibition of purified ovine COX1 pre-treated for 1 hr before 10-acetyl-3,7-dihydroxyphenoxazin substrate addition in absence of porcine liver esterase by fluorescence assay | B | 6.49 | pIC50 | 320 | nM | IC50 | ACS Med Chem Lett (2014) 5: 983-988 [PMID:25221653] |
| ChEMBL | Inhibition of ovine COX1 assessed as inhibition of PGF2alpha production from PGH2 preincubated for 5 mins before arachidonic acid addition measured after 2 mins by enzyme immunoassay | B | 6.6 | pIC50 | 250 | nM | IC50 | Eur J Med Chem (2015) 92: 115-123 [PMID:25549551] |
| ChEMBL | Inhibition of ovine COX1 using arachidonic acid as substrate incubated for 5 mins followed by substrate addition measured after 2 mins by enzyme immunoassay | B | 6.6 | pIC50 | 250 | nM | IC50 | Medchemcomm (2016) 7: 2309-2327 |
| ChEMBL | Inhibition of ovine COX1 after 2 mins by EIA | B | 6.74 | pIC50 | 180 | nM | IC50 | Eur J Med Chem (2014) 80: 167-174 [PMID:24780593] |
| ChEMBL | Inhibition of ovine COX-1 preincubated for 5 mins followed by arachidonic acid substrate addition by colorimetric enzyme immunoassay | B | 6.82 | pIC50 | 150 | nM | IC50 | Bioorg Med Chem (2017) 25: 4424-4432 [PMID:28669741] |
| ChEMBL | Inhibition of ovine COX1 using arachidonic acid as substrate incubated for 10 mins followed by substrate addition and measured after 2 mins by EIA assay | B | 7.15 | pIC50 | 70 | nM | IC50 | Bioorg Med Chem (2020) 28: 115246-115246 [PMID:31843462] |
| ChEMBL | Inhibition of ovine COX-1 using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition and measured after 2 mins by EIA | B | 7.15 | pIC50 | 70 | nM | IC50 | J Med Chem (2021) 64: 9550-9566 [PMID:34137625] |
| ChEMBL | Inhibition of ovine COX1 assessed as reduction in PGH2-derived PGF2alpha using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 2 mins by enzyme immunoassay | B | 7.15 | pIC50 | 70 | nM | IC50 | J Med Chem (2016) 59: 3920-3934 [PMID:27019010] |
| ChEMBL | Inhibition of ovine COX1 using arachidonic acid as substrate incubated for 10 mins prior to substrate addition measured after 2 mins by spectrophotometry | B | 7.15 | pIC50 | 70 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 77-82 [PMID:24332492] |
| ChEMBL | Inhibition of ovine COX1 for 17 mins pre-incubated before addition of [1-14C]arachidonic acid | B | 7.17 | pIC50 | 67 | nM | IC50 | J Biol Chem (2007) 282: 16379-16390 [PMID:17434872] |
| COX-2 /Cyclooxygenase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354] | ||||||||
| ChEMBL | Inhibition of human recombinant COX2 expressed in baculovirus infected SF21 cell | B | 4.63 | pIC50 | 23620 | nM | IC50 | Eur J Med Chem (2010) 45: 6135-6138 [PMID:20974503] |
| ChEMBL | Inhibition of human COX2 expressed in baculovirus infected sf21 cells assessed as reduction in formation of oxidized TMPD using arachidonic acid as substrate preincubated for 3 to 5 mins followed by arachidonic acid addition measured for 25 secs by spectrophotometric assay | B | 4.63 | pIC50 | 23620 | nM | IC50 | ACS Med Chem Lett (2018) 9: 1045-1050 [PMID:30344915] |
| ChEMBL | Inhibition of human recombinant COX2 pre-treated for 1 hr before 10-acetyl-3,7-dihydroxyphenoxazin substrate addition in absence of porcine liver esterase by fluorescence assay | B | 4.77 | pIC50 | 16900 | nM | IC50 | ACS Med Chem Lett (2014) 5: 983-988 [PMID:25221653] |
| ChEMBL | Inhibition of COX-2 (unknown origin) | B | 5.41 | pIC50 | 3880 | nM | IC50 | Eur J Med Chem (2023) 256: 115443-115443 [PMID:37182334] |
| ChEMBL | Inhibition of human COX2 using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 2 mins by enzyme immunoassay | B | 5.53 | pIC50 | 2940 | nM | IC50 | Eur J Med Chem (2017) 127: 10-21 [PMID:28038322] |
| ChEMBL | Inhibition of human recombinant COX2 after 2 mins by EIA | B | 5.57 | pIC50 | 2700 | nM | IC50 | Eur J Med Chem (2014) 80: 167-174 [PMID:24780593] |
| ChEMBL | Inhibition of recombinant human COX-2 using arachidonic acid as substrate preincubated with compound for 5 mins followed by substrate addition and measured after 2 mins by fluorescence spectrum analysis | B | 5.76 | pIC50 | 1730 | nM | IC50 | J Nat Prod (2023) 86: 958-965 [PMID:36880830] |
| ChEMBL | Inhibition of recombinant human COX2 using arachidonic acid as substrate pretreated for 5 mins followed by substrate addition and measured after 2 mins by fluorescence based enzyme immunoassay | B | 5.91 | pIC50 | 1240 | nM | IC50 | Eur J Med Chem (2019) 180: 86-98 [PMID:31301566] |
| ChEMBL | Inhibition of COX-2 (unknown origin) at 10 uM | B | 5.96 | pIC50 | 1100 | nM | IC50 | Eur J Med Chem (2020) 200: 112438-112438 [PMID:32485533] |
| ChEMBL | Inhibition of COX-2 (unknown origin) | B | 6.09 | pIC50 | 820 | nM | IC50 | Eur J Med Chem (2023) 256: 115443-115443 [PMID:37182334] |
| ChEMBL | Inhibition of recombinant human COX-2 | B | 6.09 | pIC50 | 820 | nM | IC50 | Eur J Med Chem (2023) 256: 115443-115443 [PMID:37182334] |
| ChEMBL | Inhibition of human recombinant COX-2 assessed as PGF2 alpha formation using arachidonic acid as substrate pretreated with compound for 20 mins prior to substrate addition by spectrophotometric analysis | B | 6.2 | pIC50 | 630 | nM | IC50 | Eur J Med Chem (2015) 97: 104-123 [PMID:25956953] |
| ChEMBL | Inhibition of human COX2 expressed in sf9 cells | B | 7.15 | pIC50 | 70 | nM | IC50 | J Nat Prod (2005) 68: 1514-1518 [PMID:16252917] |
| ChEMBL | In vitro inhibitory activity against human whole blood Prostaglandin G/H synthase 2 | B | 7.3 | pIC50 | 50 | nM | IC50 | Bioorg Med Chem Lett (1999) 9: 1773-1778 [PMID:10406640] |
| ChEMBL | Inhibition of human COX-2 preincubated for 5 mins followed by arachidonic acid substrate addition by colorimetric enzyme immunoassay | B | 7.3 | pIC50 | 50 | nM | IC50 | Bioorg Med Chem (2017) 25: 4424-4432 [PMID:28669741] |
| ChEMBL | DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) | B | 7.43 | pIC50 | 37 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| ChEMBL | Inhibition of human COX2 for 17 mins pre-incubated before addition of [1-14C]arachidonic acid | B | 7.55 | pIC50 | 28 | nM | IC50 | J Biol Chem (2007) 282: 16379-16390 [PMID:17434872] |
| ChEMBL | Inhibitory concentration against COX-2; (valus obtained by Kato et al.) | B | 7.59 | pIC50 | 26 | nM | IC50 | J Med Chem (2005) 48: 6997-7004 [PMID:16250658] |
| ChEMBL | Inhibition of human recombinant COX2 using arachidonic acid as substrate incubated for 10 mins prior to substrate addition measured after 2 mins by spectrophotometry | B | 7.7 | pIC50 | 20 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 77-82 [PMID:24332492] |
| ChEMBL | Inhibition of human recombinant COX2 assessed as reduction in PGH2-derived PGF2alpha using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 2 mins by enzyme immunoassay | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2016) 59: 3920-3934 [PMID:27019010] |
| ChEMBL | Inhibition of human COX2 using arachidonic acid as substrate incubated for 10 mins followed by substrate addition and measured after 2 mins by EIA assay | B | 7.7 | pIC50 | 20 | nM | IC50 | Bioorg Med Chem (2020) 28: 115246-115246 [PMID:31843462] |
| ChEMBL | Inhibition of human COX-2 using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition and measured after 2 mins by EIA | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2021) 64: 9550-9566 [PMID:34137625] |
| ChEMBL | Inhibition of COX2 | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2007) 50: 1425-1441 [PMID:17341061] |
| GtoPdb | - | - | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2007) 50: 1425-41 [PMID:17341061] |
| ChEMBL | Inhibition of COX2 in LPS-stimulated human blood | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem (2009) 17: 558-568 [PMID:19097798] |
| ChEMBL | Inhibitory concentration against COX-2 upon incubation for 15 minutes at 37 degree C | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2005) 48: 6997-7004 [PMID:16250658] |
| ChEMBL | Inhibition of COX2 | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2012) 55: 2932-2942 [PMID:22236250] |
| Cyclooxygenase-2 in Sheep (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4102] [UniProtKB: P79208] | ||||||||
| ChEMBL | Inhibition of ovine COX2 peroxidase activity assessed as reduction of PGG2 to PGH2 by measuring oxidized TMPD level by colorimetric assay | B | 4.82 | pIC50 | 15000 | nM | IC50 | Bioorg Med Chem (2014) 22: 2855-2866 [PMID:24751552] |
| ChEMBL | Inhibition of ovine COX2 assessed as inhibition of PGF2alpha production from PGH2 preincubated for 5 mins before arachidonic acid addition measured after 2 mins by enzyme immunoassay | B | 5.38 | pIC50 | 4200 | nM | IC50 | Eur J Med Chem (2015) 92: 115-123 [PMID:25549551] |
| ChEMBL | Inhibition of ovine COX -2 by colorimetric inhibitor screening assay kit method | B | 6.1 | pIC50 | 800 | nM | IC50 | Eur J Med Chem (2019) 167: 161-186 [PMID:30771604] |
| ChEMBL | Inhibition of ovine COX2 using arachidonic acid as substrate incubated for 5 mins followed by substrate addition measured after 2 mins by enzyme immunoassay | B | 6.59 | pIC50 | 260 | nM | IC50 | Medchemcomm (2016) 7: 2309-2327 |
| ChEMBL | Inhibition of sheep placental cotyledons COX2 | B | 7.22 | pIC50 | 60 | nM | IC50 | J Med Chem (2011) 54: 8555-8562 [PMID:22091869] |
| COX-2 /Cyclooxygenase-2 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4321] [GtoPdb: 1376] [UniProtKB: Q05769] | ||||||||
| ChEMBL | Inhibition of purified mouse COX-2 assessed as inhibition of PGE2/PGD2 formation preincubated for 15 mins before arachidonic acid substrate addition measured after 30 seconds by LC-MS-MS method | B | 7 | pIC50 | 100 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 5860-5864 [PMID:24060487] |
| ChEMBL | Inhibition of mouse wild type COX2 | B | 7.11 | pIC50 | 77 | nM | IC50 | J Med Chem (2007) 50: 1425-1441 [PMID:17341061] |
| ChEMBL | Inhibition of purified mouse COX-2 assessed as inhibition of PGE2-G/PGD2-G formation preincubated for 15 mins before 2-AG substrate addition measured after 30 seconds by LC-MS-MS method | B | 7.52 | pIC50 | 30 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 5860-5864 [PMID:24060487] |
| ChEMBL | Inhibition of mouse COX2 for 17 mins pre-incubated before addition of [1-14C]arachidonic acid | B | 7.66 | pIC50 | 22 | nM | IC50 | J Biol Chem (2007) 282: 16379-16390 [PMID:17434872] |
| ChEMBL | Inhibition of mouse COX2 for 20 mins pre-incubated before addition of [1-14C]arachidonic acid | B | 7.66 | pIC50 | 22 | nM | IC50 | J Biol Chem (2007) 282: 16379-16390 [PMID:17434872] |
| Cytochrome c oxidase subunit 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6174] [UniProtKB: P00403] | ||||||||
| ChEMBL | Inhibition of recombinant human COX2 expressed in baculovirus infected Sf21 cells using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition and measured after 5 mins by UV-visible spectrophotometric method | B | 5 | pIC50 | 10050 | nM | IC50 | Eur J Med Chem (2020) 186: 111863-111863 [PMID:31740050] |
| fatty acid binding protein 1/Fatty acid-binding protein, liver in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5738] [GtoPdb: 2531] [UniProtKB: P02692] | ||||||||
| ChEMBL | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP low binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay | B | 4.45 | pKi | 35400 | nM | Ki | J Med Chem (2008) 51: 3755-3764 [PMID:18533710] |
| ChEMBL | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay | B | 5.49 | pKi | 3220 | nM | Ki | J Med Chem (2008) 51: 3755-3764 [PMID:18533710] |
| Interleukin-8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2157] [UniProtKB: P10145] | ||||||||
| ChEMBL | Inhibition of CXCL8-induced chemotaxis in human polymorphonuclear leukocyte pretreated for 15 mins measured after 4 hrs by cell migration assay | B | 8.1 | pIC50 | 8 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4026-4030 [PMID:19560921] |
| CXCR1/Interleukin-8 receptor A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4029] [GtoPdb: 68] [UniProtKB: P25024] | ||||||||
| ChEMBL | Inhibition of CXCR1 Lys99Ala mutant transfected in mouse L1.2 cells assessed as inhibition of CXCL8-induced cell migration pretreated for 15 mins measured after 4 hrs | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4026-4030 [PMID:19560921] |
| ChEMBL | Inhibition of wild type CXCR1 transfected in mouse L1.2 cells assessed as inhibition of CXCL8-induced cell migration pretreated for 15 mins measured after 4 hrs | B | 7.92 | pIC50 | 12 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4026-4030 [PMID:19560921] |
| FPR3/N-formyl peptide receptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5646] [GtoPdb: 224] [UniProtKB: P25089] | ||||||||
| ChEMBL | GPCR PRESTO-Tango dose-response in antagonist mode with target: FPR3 | F | 5 | pIC50 | >10000 | nM | IC50 | EUbOPEN Chemogenomics Library - GPCR Dose-Respose |
| Organic anion transporter 1/Solute carrier family 22 member 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1641347] [GtoPdb: 1025] [UniProtKB: Q4U2R8] | ||||||||
| ChEMBL | TP_TRANSPORTER: inhibition of Adefovir uptake in OAT1-expressing CHO cells | F | 5.4 | pIC50 | 4000 | nM | IC50 | J Pharmacol Exp Ther (2000) 295: 10-15 [PMID:10991954] |
| TRPA1/Transient receptor potential cation channel subfamily A member 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6007] [GtoPdb: 485] [UniProtKB: O75762] | ||||||||
| ChEMBL | Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assay | B | 4.2 | pEC50 | 63095.73 | nM | EC50 | Eur J Med Chem (2019) 170: 141-156 [PMID:30878828] |
| ChEMBL | Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assay | B | 4.25 | pEC50 | 56000 | nM | EC50 | Eur J Med Chem (2019) 170: 141-156 [PMID:30878828] |
| transthyretin/Transthyretin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3194] [GtoPdb: 2851] [UniProtKB: P02766] | ||||||||
| ChEMBL | Binding affinity to TTR (unknown origin) by isothermal titration calorimetric analysis | B | 6 | pKd | 1000 | nM | Kd | J Med Chem (2015) 58: 6507-6515 [PMID:26214366] |
| ChEMBL | Binding affinity to wild type TTR (unknown origin) expressed in Escherichia coli BL21/DE3 by Circular dichroism spectroscopy | B | 7.22 | pKd | 60 | nM | Kd | J Med Chem (2020) 63: 14228-14242 [PMID:32914975] |
| UDP glucuronosyltransferase family 1 member A1/UDP-glucuronosyltransferase 1-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1287617] [GtoPdb: 2990] [UniProtKB: P22309] | ||||||||
| ChEMBL | Inhibition of 4-methylumbelliferone glucuronidation by human recombinant UGT1A1 | B | 4.28 | pKi | 52000 | nM | Ki | Pharmacol Ther (2005) 106: 97-132 [PMID:15781124] |
| UDP-glucuronosyltransferase 1-10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743320] [UniProtKB: Q9HAW8] | ||||||||
| ChEMBL | Inhibition of 4-methylumbelliferone glucuronidation by human recombinant UGT1A10 | B | 4.55 | pKi | 28000 | nM | Ki | Pharmacol Ther (2005) 106: 97-132 [PMID:15781124] |
| UDP-glucuronosyltransferase 1-6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743316] [UniProtKB: P19224] | ||||||||
| ChEMBL | Inhibition of 4-methylumbelliferone glucuronidation by human recombinant UGT1A6 | B | 4.64 | pKi | 23000 | nM | Ki | Pharmacol Ther (2005) 106: 97-132 [PMID:15781124] |
| UDP-glucuronosyltransferase 1-7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743317] [UniProtKB: Q9HAW7] | ||||||||
| ChEMBL | Inhibition of 4-methylumbelliferone glucuronidation by human recombinant UGT1A7 | B | 4.72 | pKi | 19000 | nM | Ki | Pharmacol Ther (2005) 106: 97-132 [PMID:15781124] |
| UDP-glucuronosyltransferase 1-9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743319] [UniProtKB: O60656] | ||||||||
| ChEMBL | Inhibition of 4-methylumbelliferone glucuronidation by human recombinant UGT1A9 | B | 4.96 | pKi | 11000 | nM | Ki | Pharmacol Ther (2005) 106: 97-132 [PMID:15781124] |
| Cav1.2/Voltage-gated L-type calcium channel alpha-1C subunit in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3762] [GtoPdb: 529] [UniProtKB: P22002] | ||||||||
| ChEMBL | Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes | F | 4.89 | pIC50 | 12890 | nM | IC50 | J Appl Toxicol (2012) 32: 858-866 [PMID:22761000] |
| TRPM3 in Human [GtoPdb: 495] [UniProtKB: Q9HCF6] | ||||||||
| GtoPdb | - | - | 5.2 | pIC50 | - | - | - | Pharmacol Res Perspect (2016) 4: e00232 [PMID:27433342] |
| Peroxisome proliferator-activated receptor-γ in Human [GtoPdb: 595] [UniProtKB: P37231] | ||||||||
| GtoPdb | - | - | 6.2 | pKi | - | - | - | Mol Pharmacol (2002) 61: 7-12 [PMID:11752200] |
| ASIC3 in Human [GtoPdb: 686] [UniProtKB: Q9UHC3] | ||||||||
| GtoPdb | - | - | 4 | pIC50 | 92000 | nM | IC50 | J Neurosci (2001) 21: 8026-33 [PMID:11588175] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
